✦ LIBER ✦

P102 Adjuvant high-dose medroxyprogesterone acetate (HD-MPA) for early breast cancer. 13 years update of a multicenter randomized trial

✍ Scribed by C. Focan; M. Beauduin; E. Salamon; J. de Greve; G. de Wasch; J.P. Lobelle; F. Majois; A. Tagnon; J. Tytgat; S. Van Belle; R. Vandervellen; A. Vindevoghel

Book ID: 117665537
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 157 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)89319-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

56 Improvement of prognosis irrespective

56 Improvement of prognosis irrespective of age in early node negative early breast cancer by adjuvant high-dose medroxyprogesterone acetate (HD-MPA); ten years results of a multicenter randomized trial

✍ C. Focan; M. Beauduin; E. Salamon; J. de Grève; G. de Wasch; P. Lobelle; F. Majo 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Medroxyprogesterone acetate high-dose (H

Medroxyprogesterone acetate high-dose (HD-MPA) vs HD-MPA plus bromocriptine (Br) in advanced breast cancer: Preliminary results of a multicentric randomized trial

✍ Dogliotti, L.; Robustelli della Cuna, G.; Di Carlo, F. 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 163 KB

46 Unexpected opposite age related effec

46 Unexpected opposite age related effect of adjuvant high-dose progesterone acetate (HD-MPA) for node positive (NP) early breast cancer: 10 years results of a multicenter randomized trial

✍ C. Focan; M. Beauduin; E. Salamon; J. de Gréve; G. de Wasch; J.P. Lobelle; F. Ma 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 133 KB

High-Dose Oral Medroxyprogesterone Aceta

High-Dose Oral Medroxyprogesterone Acetate or Tamoxifen as Adjuvant Hormone Therapy for Node-Negative Early-Stage Breast Cancer: Randomized Trial with 7-Year Update

✍ Christian Focan; Marc Beauduin; Françoise Majois; Jean-Luc Canon; Giuseppe Cusum 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 153 KB